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Abstract
Data on early markers for acute kidney injury (AKI) after noncardiovascular surgery are still limited. This study aimed to determine the
diagnostic value of plasma neutrophil-gelatinase-associated lipocalin (pNGAL) and intraoperative diuresis for AKI in patients
undergoing major abdominal surgery treated within a goal-directed hemodynamic algorithm.
This study is a post-hoc analysis of a randomized controlled pilot trial comparing intravenous solutions within a hemodynamic goal-
directed algorithm based on the esophageal Doppler in patients undergoing epithelial ovarian cancer surgery. The diagnostic value of
plasma NGAL obtained at ICU admission and intraoperative diuresis was determined with respect to patients already meeting AKI
criteria 6hours after surgery (AKI6h) and to all patients meeting AKI criteria at least once during the postoperative course (AKItotal). AKI
was diagnosed by the deﬁnition of the Kidney Disease Improving Global Outcome (KDIGO) group creatinine criteria and was
screened up to postoperative day 3. Receiver operating characteristic curves including a gray zone approach were performed.
A total of 48 patients were analyzed. None of the patients had increased creatinine levels before surgery and 14 patients (29.2%)
developed AKI after surgery. Plasma NGAL was predictive for AKI6h (AUCAKI6h 0.832 (95% conﬁdence interval [CI], 0.629–0.976),
P= .001) andAKItotal (AUCAKItotal 0.710 (CI 0.511–0.878),P= .023). The gray zones of pNGALcalculated for AKI6h andAKItotal were 210
to 245 and207 to 274 ngmL1, respectively. The lower cutoffs of the gray zone at 207 and 210 ngmL1 had a negative predictive value
(NPV) (i.e., noAKIduring thepostoperative course) of 96.8% (CI 90–100) and87.1% (CI 78–97), respectively. Intraoperativediuresiswas
alsopredictive forAKI6h (AUCAKI6h 0.742 (CI 0.581–0.871),P= .019)with a gray zone of 0.5 to 2.0mLkg
1 h1. At the lower cutoff of the
gray zone at 0.5 mL kg1 h1, corresponding to the oliguric threshold, the NPV was 84.2% (78–92).
This study indicates that pNGAL can be used as an early marker to rule out AKI occurring within 3 days after major abdominal
surgery. Intraoperative diuresis can be used to rule out AKI occurring up to 6hours after surgery.
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1. Introduction Charité—University Medicine Berlin (No. EK 12/581/08). ThePerioperative acute kidney injury (AKI) is a serious and often
under-appreciated complication associated with an increased
morbidity, mortality, and healthcare costs.[1,2] AKI after major
surgery has been shown to be an independent predictor for in-
hospital mortality and even affects long-term survival in patients
with preoperative normal renal function.[3,4]
In recent years, the understanding of AKI has changed as it has
been shown that even small and temporary increased creatinine
levels are related to short and long-term mortality.[5–9] While the
urine output criteria for AKI diagnosis remained unchanged, the
Kidney Disease Improving Global Outcome (KDIGO) group
published revised diagnostic creatinine criteria, deﬁning AKI as
an abrupt decrease of kidney function within 48hours and
implied smaller changes of serum creatinine levels from baseline
(>0.3mg dL1) as diagnostic criterion.[10] However, due to the
intrinsic properties of serum creatinine limiting its use for early
diagnosis,[11] there is still a substantial need for early biomark-
ers.[12]
In this regard, neutrophil gelatinase-associated lipocalin
(NGAL) has emerged as a promising early biomarker of AKI.
In animal models NGAL has been shown to be upregulated in the
kidney very early after AKI.[13] Plasma NGAL primarily
originates from the damaged kidneys via tubular back-leak
and has been shown as an early marker to predict AKI in different
hospital settings.[14–16] In the perioperative setting, pNGAL has
been investigated after cardiovascular surgery,[17–20] but to date,
data on predictive ability of pNGAL in patients after major
noncardiovascular and nonvascular surgery are still limited.[21]
Furthermore, intraoperative diuresis as a functional kidney
marker may help to identify patients at risk for AKI during the
postoperative course.[22] A decreased diuresis as a criterion for
AKI diagnosis has been implemented in the current diagnostic
classiﬁcations for many years as it was supposed that a decrease
in diuresis below oliguric threshold was directly related to a
decreased glomerular ﬁltration rate.[23,24] However, the associa-
tion of intraoperative diuresis with perioperative AKI and its
potential diagnostic value are still not evaluated.
We hypothesized that pNGAL and intraoperative diuresis
might be used as early markers for the diagnosis of AKI occurring
after noncardiovascular surgery.
This study aimed to investigate the diagnostic value of pNGAL
obtained at admission to the intensive care unit and intraoper-
ative diuresis with regard to AKI after noncardiovascular surgery.Figure 1. Blood sampling of creatinine and NGAL and assessment of diuresis.2. Methods
This study is a post-hoc secondary analysis of a previously
published randomized controlled trial comparing a balanced
crystalloid with a balanced colloid within a goal-directed
hemodynamic algorithm (BalaCriCo, ISRCTN 53154834).[25]
Eligible patients were adults undergoing laparotomy for
cytoreductive surgery due to primary ovarian cancer. The entire
data were obtained from the per-protocol group of the BalaCriCo
trial. Ethics approval was given by Ethics Committee of2trial was conducted at Charité—University Medicine Berlin,
Campus Virchow Klinikum, Berlin, Germany and written
informed consent was obtained from all patients.2.1. Intraoperative hemodynamic management
The hemodynamic management was performed according to an
outcome-based goal-directed hemodynamic algorithm guided by
the esophageal Doppler monitor (EDM, CardioQ-ODM, Deltex
Medical, Chichester, UK) as published previously.[26]2.2. Outcomes
AKI was deﬁned as Kidney Disease Improving Global Outcome
(KDIGO) stage 1 or higher using creatinine criteria and was
screened up to postoperative day 3 (POD3).
The diagnostic value of pNGAL (obtained after surgery at
admission to the intensive care unit) and intraoperative diuresis
(cumulative diuresis at the end of surgery adjusted for duration of
surgery and patients weight [mL kg1 h1]) was determined with
respect to patients, who were already meeting the KDIGO criteria
6hours after surgery (AKI6h); and patients who were meeting the
KDIGO criteria at least once at any time point during the
postoperative course up to POD3 (AKItotal).2.3. Sampling and biomarker measurement
Regarding the measurements of plasma creatinine, blood samples
were obtained at the day before surgery, at 1 and 6hours after
surgery and on postoperative day 1 (POD1) and 3 (POD3)
(Fig. 1). Creatinine from heparin-plasma samples was measured
using the analyzer COBAS 6000 (Roche Diagnostics, Mannheim,
Germany). Plasma NGAL was measured at admission to the
intensive care unit (sampling corresponded to 1 hour after the
end of surgery (skin closing)). Plasma NGAL samples were
centrifuged at 2000g for 5 minutes and the supernatant was
pipetted and stored at 80°C until measurement. The concen-
tration of heparin-plasma NGAL was measured with a particle-
enhanced turbidimetric immunoassay, NGAL-Test (BioPorto
Diagnostics A/S) also on COBAS 6000 analyzer.
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Because of limited sample sizes and deviations from normal
distribution of the observations, data were expressed as median
(25%, 75% quartiles) or frequencies (%), respectively. Differ-
ences with respect to continuous data were tested using the exact
Mann–WhitneyU test for independent groups, while frequencies
were tested by the Fisher exact test. Differences in continuous
data with respect to time were analyzed using nonparametric
analysis for longitudinal data in a 2-factorial design (1st factor:
groups, 2nd factor: time).[27]
To assess the diagnostic value of pNGAL and intraoperative
diuresis with respect to AKI6h and AKItotal receiver operating
characteristic (ROC) curves including a gray zone approach were
calculated. This approach avoids a single cutoff that dichoto-
mizes the population. In contrast, the gray zone approach
provides 2 cutoffs: the lower cutoff of the gray zone will rule out
AKI with near certainty and the upper cutoff will rule in AKI with
near certainty.[28] Consequently, this approach allows clinical
decision making with respect to AKI. First, the area under the
curve (AUCROC) and 95%CIs were computed by averaging 1000
populations bootstrapped from the study population. Second, the
best cutoff was determined maximizing the Youden index.[29]
The best cutoff determination was conducted for a 1000
populations bootstrapped from the study population. The mean
value and its 95% CI were then estimated. Finally, the gray zone
was deﬁned as 95%CI of the best cutoff.[30] For visualization, the
gray zone was included into a boxplot presentation comparing
patients without AKI and with AKI with respect to pNGAL and
intraoperative diuresis.
A 2-tailed P value<.05 was considered statistically signiﬁcant.
All numerical calculations were performed with the R project for
Statistical Computing, Version 3.0.1 (R-packages used: nparLD,
foreign, gplots, pROC, ROCR).
3. Results
A total of 48 patients were analyzed according to the per-protocol
group of the main study (Supplemental Digital Content—
Figure S1, http://links.lww.com/MD/B782).
None of the patients had known chronic kidney disease or
increased creatinine levels before surgery. According to KDIGO
creatinine criteria, a total of 14 patients (29.2%) developed AKI
after surgery. Ten patients (20.8%) had early AKI, diagnosed
within 6hours after admission to the intensive care unit, while all
patients who developed AKI were diagnosed up to the ﬁrst
postoperative day (POD1). Ten patients had KDIGO stage 1
(20.8%), 1 patient stage 2 (2.1%), and 3 patients stage 3 (6.3%),
respectively. On POD3, only 2 patients (4.2%) had still AKI,
while all other patients had normalized creatinine values, no
longer meeting KDIGO criteria. One patient in the AKI group
(7.1%) needed renal replacement therapy.
In the publication of the main study a nonparametric
longitudinal data analysis of the perioperative time courses of
the plasmatic values of creatinine revealed no differences between
the crystalloid and the colloid solution.[25] However, applying
analyses with respect to KDIGO criteria revealed a higher
frequency of patients in the AKI group who had been randomized
to receive balanced colloid.
Perioperative characteristics of the study patients are shown in
Table 1. Patients developing AKI had more severe cancer stage,
longer duration of surgery, longer periods of preoperative fasting,
and higher perioperative inﬂammatory markers but did not differ
in intraoperative and postoperative hemodynamic variables3(Table 1, Supplemental Digital Content—Figures S2–4, http://
links.lww.com/MD/B782).3.1. Diagnostic value of plasma NGAL
PlasmaNGALwas higher in patients meeting the KDIGO criteria
6hours after surgery and in patients meeting the KDIGO criteria
at least once at any time point during the postoperative course
(266 [242; 302] vs 174 [149; 200] ng mL1, P= .001 and 244
[184; 291] vs 175 [150; 200] ng mL1, P= .023) (Fig. 2). Plasma
NGAL was predictive for AKI6h (AUCAKI6h 0.832 (95%
conﬁdence interval [CI], 0.629–0.976), P= .001) and AKItotal
(AUCAKItotal 0.710 (CI 0.511–0.878), P= .023). The gray zones
of pNGAL calculated for AKI6h and AKItotal were 210 to 245 and
207 to 274 ng mL1, respectively. The lower cutoffs of the gray
zone at 207 and 210 ng mL1 had negative predictive values
(NPV) of 96.8% (CI 90–100) and 87.1% (CI 78–97), and the
upper cutoffs of the gray zone at 245 and 274 ng mL1 had
positive predictive values of 63.6% (CI 42–89) and 71.4%
(40–100), respectively (Table 2).
3.2. Diagnostic value of intraoperative diuresis
Intraoperative diuresis was lower in patients meeting the KDIGO
criteria 6hours after surgery but did not differ between patients
not meeting and meeting the KDIGO criteria at least once at any
time point during the postoperative course (0.64 [0.41; 1.48] vs
1.85 [0.73; 2.68] mL, P= .019 and .83 [0.52; 1.68] vs 1.85 [0.67;
2.68] mL, P= .083) (Fig. 3). Intraoperative diuresis, adjusted for
duration of surgery and patients’ weight, was predictive for
AKI6h (AUCAKI6h 0.742 (CI 0.581–0.871), P= .019) with a gray
zone of 0.5 to 2.0 mL kg1 h1. The lower cutoff of the gray zone
at 0.5 mL kg1 h1, coextensive with the known oliguric
threshold, had a PPV of 40.0% (CI 14–71), and the upper cutoff
of the gray zone at 2.0 mL kg1 h1 had a NPV of 100% (CI
100–100), respectively (Table 2). The lower cutoff at 0.5mL kg1
h1 indicated a NPV of 84.2% (78–92). Intraoperative diuresis
was not predictive for AKItotal (AUCAKItotal 0.661 (0.495–0.808),
P= .083).
4. Discussion
The principal ﬁndings of the study are that pNGAL was
predictive for AKI occurring 6hours after surgery and even for
AKI occurring within the ﬁrst 3 days after surgery; that the lower
cutoffs of the gray zone of pNGAL had high negative predictive
values allowing to early rule out AKI after surgery; that
intraoperative diuresis was also predictive for AKI occurring 6
hours after surgery, but not for AKI occurring within the ﬁrst 3
days after surgery; and that the lower cutoff of the gray zone of
intraoperative diuresis, coextensive with the known oliguric
threshold, had a low positive predictive value, but a good
negative predictive value also allowing to rule out AKI, but only
with respect to AKI occurring 6hours after surgery.
Whereas the primary nonparametric longitudinal analysis of
the time course of renal markers in the main study[25] showed no
statistical differences for plasmatic creatinine and pNGAL, intra-
and postoperative diuresis, the classiﬁcation of the patients
according to the KDIGO criteria in this substudy of the
BalaCriCo trial revealed a higher incidence and higher levels
of AKI in the group of patients randomized to balanced
hydroxyethyl starch. Even small increases of creatinine are
related to worse outcome,[5–8] accordingly the analysis of the
Table 1
Perioperative data of the study patients.
Non-AKI (n=34) AKI (n=14) P value
Age, y 53 (47; 59) 60 (48; 67) .137
Body mass index, kg/m2 24.9 (22.8; 28.4) 26.0 (24.3; 30.4) .328
Randomized to balanced crystalloid, n, % 21 (87.5) 3 (12.5) .024
Randomized to balanced colloid, n, % 13 (54.2) 11 (45.8)
American Society of Anesthesiology (ASA)
ASA Physical Status I, n, % 2 (5.9) 2 (14.3)
ASA Physical Status II, n, % 16 (47.1) 8 (57.1) .211
ASA Physical Status III, n, % 16 (47.1) 4 (28.6)
Pre-existing Arterial Hypertension, n, % 10 (29.4) 3 (21.4) .728
Pre-existing Diabetes mellitus, n, % 1 (2.9) 2 (14.3) .200
FIGO classiﬁcation
Stadium 1, n, % 5 (17.2) 0 (0)
Stadium 2, n (%) 6 (20.6) 0 (0)
Stadium 3a, n, % 4 (13.8) 1 (9.1) .020
Stadium 3b, n, % 5 (17.2) 3 (27.3)
Stadium 3c, n, % 9 (31.0) 7 (63.6)
Chronic medications
Beta blocker, n, % 7 (20.6) 3 (21.4) 1.000
ACE inhibitors, n, % 4 (11.8) 3 (21.4) .656
AT1 receptor antagonists, n, % 2 (5.9) 1 (7.1) 1.000
Statins, n, % 5 (14.7) 1 (7.1) .656
Diuretics, n, % 5 (14.7) 1 (7.1) .656
Other medications, n, % 6 (17.6) 3 (21.4) 1.000
POSSUM score[37]
Possum physiologic score 14.0 (13.0; 17.0) 14.0 (13.0; 16.0) .941
Possum operative score 31.0 (28.7; 33.3) 36.0 (30.0; 37.0) .046
Possum score 46.0 (42.7; 50.2) 49.5 (46.7; 53.0) .083
Risk prediction morbidity, % 91.5 (85.8; 96.2) 95.7 (91.7; 97.6) .068
Risk prediction mortality, % 15.1 (9.4; 25.2) 22.9 (16.9; 33.9) .092
Preoperative Creatinine, mg/dL 0.62 (0.57; 0.72) 0.58 (0.49; 0.64) .097
Preoperative Creatinine Clearance (CKD-EPI), mL min1 1.73 m2 102.9 (96.2; 109.1) 103.3 (96.2; 105.9) .991
Preoperative fasting of ﬂuids, h 10 (7; 13) 14 (11; 20) .038
Preoperative fasting of solids, h 21 (18; 25) 22 (18; 25) .646
Duration of surgery, hh:min 3:48 (3:11; 4:52) 5:17 (4:24; 6:16) .008
Baseline infusion, mL kg1 h1 3.38 (2.29; 7.54) 3.20 (2.54; 5.13) .765
Crystalloid infusion within GDT, mL/kg 48.7 (0; 50) 0 (0; 8.6) .006
Colloid infusion within GDT, mL/kg 0 (0; 29.3) 46.3 (19.6; 50) .007
Intraoperative diuresis, mL kg1 h1 1.85 (0.67; 2.68) 0.83 (0.52; 1.68) .083
Hospital length of stay, dd/hh 12/23 (10/23; 17/00) 15/23 (13/11; 22/22) .068
Length of stay in ICU, dd/hh 00/18 (00/05; 01/14) 01/23 (00/17; 03/06) .041
Total number of complications according to Clavien classiﬁcation (number) 2.0 (1.0; 3.0) 3.5 (2.0; 6.0) .014
Data are shown as median (25%; 75%) quartiles or as n (%) patients. P values calculated using the exact Wilcoxon–Mann–Whitney test and the Fisher exact test, or the exact Mantel–Haenszel test as appropriate.
POSSUM=Physiologic and Operative Severity Score for the enumeration of Mortality and Morbidity.
Hunsicker et al. Medicine (2017) 96:28 Medicinestudy population following the KDIGO criteria is more
appropriate than the nonparametric statistical analysis based
on medians and quartiles in the intensive care environment.[31,32]
In recent years, perioperative AKI has been shown to be
multifactorial determined and to date several patient and surgery-
related factors risk factors have been identiﬁed.[2] It is supposed
that most patients with AKI had episodes of hemodynamic
instability during surgery followed by an ischemia-reperfusion
injury.[33,34] In this regard, an intraoperative hemodynamic
optimization has been stated as to date the most important
preventive measure.[1,35] Interestingly, in our study population,
which was treated within a goal-directed hemodynamic algo-
rithm, we did not observe any differences in perioperative
hemodynamic courses between AKI and non-AKI group. The
longer period of preoperative fasting of clear ﬂuids in the AKI
group indicates to date underappreciated determinant for AKI.
There was still a lack regarding the diagnostic value of pNGAL
after major noncardiovascular surgery. We investigated the4diagnostic value of pNGAL with respect to AKI occurring in an
early period after surgery (KDIGO criteria had to be applied 6
hours after surgery) and with respect to AKI occurring during a
longer period (KDIGO criteria had to be applied within 3 days
after surgery). Our results show that plasma NGAL had a good
predictive value for patients experiencing early AKI and a fair
predictive value for all patients developing AKI within the ﬁrst 3
days after surgery. The minor predictive value of pNGAL for all
the patients meeting the KDIGO criteria up to postoperative day
3 was referred to a reduced sensitivity whereas speciﬁcity was still
preserved. A similar ROC curve conﬁguration was found in ICU
patients in regard to predict AKI within 48hours and a further
decrease of sensitivity was shown in the prediction of AKI within
5 days after obtaining plasma NGAL, while speciﬁcity was still
acceptable.[36] The AUCs of pNGAL observed in our analysis are
in good agreement with overall results from a systematic review
in 7000 cardiac surgery patients.[15] From a clinical perspective













































































Figure 2. Comparison of pNGAL between patients without AKI and patients meeting the KDIGO criteria 6h after surgery (A); and patients meeting the KDIGO
criteria at least once at any time point during the postoperative course up to POD3 (B). The boxplot presentation includes a gray zone approach obtained by the
95% conﬁdence interval of the best cutoff calculated from receiver operating characteristic (ROC) curve. The corresponding ROC curve is shown with sensitivities
and speciﬁcities of the lower and upper cutoff of the gray zone. AUC=area under the receiver operating characteristic curve.
Hunsicker et al. Medicine (2017) 96:28 www.md-journal.comwhite” decision of the ROC curve approach and allows better
clinical decision making when evaluating a biomarker.[28,30]
Furthermore, we calculated positive and negative predictive
values of the cutoffs of the gray zone as sensitivities and
speciﬁcities are of no practical use in clinical routine when it
comes to helping the clinician estimate the probability of disease
in individual patients.[37] Our results indicated that the lower
cutoffs of the gray zone of 210 and 207 ng mL1 were similar for
early AKI and AKI occurring within the ﬁrst 3 days. Both of these
cutoffs had high negative predictive values indicating that
approximately 9 of 10 patients will not develop AKI if pNGAL
measured at ICU admission is below the lower cutoff. In contrast,
the upper cutoffs gray zone had moderate positive predictive
values allowing us to identify only approximately 7 of 10 patients
who will develop AKI if pNGAL measured at ICU admission is
above the upper cutoff. Thus, our results suggest that pNGAL can
be used as an early marker to rule out AKI, but not to identify
patients who will develop AKI within the ﬁrst 3 days after major
abdominal surgery.
Intraoperative diuresis as a functional kidney marker may help
to identify patients at risk for AKI during the postoperative
course. We found that intraoperative diuresis was predictive for
early AKI, but not for AKI occurring within the ﬁrst 3 days after
surgery. Although intraoperative diuresis was higher in patients
not developing early AKI, there was a wide distribution of values5indicating that there are polyuric, normouric, and even oliguric
patients who will not develop early AKI after surgery. In this
regard, the lower cutoff of the gray zone, coexistent with the
oliguric threshold at 0.5 mL kg1 h1, showed poor positive
predictive value suggesting that many oliguric patients do not
develop AKI after surgery. These ﬁndings are consistent with
ﬁndings regarding diuresis obtained during ICU stay in a mixed
critical care population also reporting good negative and poor
positive predictive values for episodes of oliguria.[38] Interesting-
ly, oliguria can occur in patients with preserved hemodynamics
due to excess ADH secretion despite lacking volume or osmolar
stimulus.[39] In this context, it has been shown that oliguria is
common during ICU stay, but most oliguric episodes are not
followed by a signiﬁcant creatinine increase and most AKI is not
preceded by oliguric episodes.[38,40] However, our results also
indicate a good negative predictive value at the oliguric threshold
indicating that approximately 8 of 10 patients will not develop
AKI if patients were not oliguric during the course of surgery.
From a clinical point of view, intraoperative diuresis as functional
kidney marker is only predictive for AKI occurring early after
surgery. In this regard, the oliguric threshold can be used to rule
out AKI, but cannot be used to identify patients developing AKI.
The study has some limitations and strengths. Post-hoc
analyses of randomized controlled trials commonly have to





























































































Figure 3. Comparison of intraoperative diuresis between patients without AKI and patients meeting the KDIGO criteria 6hours after surgery (A); and patients
meeting the KDIGO criteria at least once at any time point during the postoperative course up to POD3 (B). The boxplot presentation includes a gray zone approach
obtained by the 95% conﬁdence interval of the best cutoff calculated from receiver operating characteristic (ROC) curve. The corresponding ROC curve is shown
with sensitivities and speciﬁcities of the lower and upper cutoff of the gray zone. AUC=area under the receiver operating characteristic curve.
Table 2
Performance of lower and upper cutoff of the gray zone of intraoperative diuresis and pNGAL with respect to patients already meeting
KDIGO criteria 6h after surgery (AKI6h) and patients meeting KDIGO criteria at least once during the postoperative course (AKItotal).
Sensitivity, % (95% CI) Speciﬁcity, % (95% CI) PPV, % (95% CI) NPV, % (95% CI)
Intraoperative Diuresis
AKI6h
<0.5 mL kg1 h1 (LC) 40.0 (10–70) 84.2 (71–95) 40.0 (14–71) 84.2 (78–92)
<2.0 mL kg1 h1 (UC) 100 (100–100) 44.7 (29–61) 32.2 (27–40) 100 (100–100)
AKItotal
<0.6 mL kg1 h1 (LC) 28.6 (7–50) 76.5 (62–88) 33.3 (9–57) 72.2 (65–80)
<2.9 mL kg1 h1 (UC) 100 (100–100) 23.5 (9–38) 35.0 (31–40) 100 (100–100)
Pngal
AKI6h
>210 ng mL1 (LC) 90.0 (70–100) 78.9 (66–92) 52.9 (39–73) 96.8 (90–100)
>245 ng mL1 (UC) 70.0 (40–90) 89.5 (79–97) 63.6 (42–89) 91.9 (85–97)
AKItotal
>207 ng mL1 (LC) 71.4 (50–93) 79.4 (65–91) 58.8 (42–80) 87.1 (78–97)
>274 ng mL1 (UC) 35.7 (14–64) 94.1 (85–100) 71.4 (40–100) 78.1 (72–86)
LC= lower cutoff of the gray zone, NPV=negative predictive value, PPV=positive predictive value, UC=upper cutoff of the gray zone.
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[13] Mishra J, Ma Q, Prada A, et al. Identiﬁcation of neutrophil gelatinase-
Hunsicker et al. Medicine (2017) 96:28 www.md-journal.comconstitute themost important confounding factors. In this regard,
we cannot exclude that the results of this subanalysis have been
biased by the interventions of the main study, but as analyses of
the main study showed that there was no difference between the
crystalloid and colloid group with respect to NGAL levels and
there is not any evidence that the predictive ability of NGAL with
respect to postoperative AKI might be inﬂuenced by the choice of
the artiﬁcial infusion solution administered during surgery, the
risk of bias is low. In addition, the sample size of the study is small
which results from being a post-hoc secondary analysis of a pilot
study and therefore the power of the speciﬁc analysis cannot be
stated. The study population is a speciﬁc gynecological surgical
selection of patients, but due to the well-deﬁned surgical
procedures, it provides an excellent surgical model in abdominal
high-risk surgery.
In conclusion, pNGAL can be used as early marker to rule out
AKI, but not to identify patients who will develop AKI within the
ﬁrst 3 days after major abdominal surgery. In patients with
absence of intraoperative oliguria (<0.5mL1kg h1), risk for
early AKI following surgery was low, whereas in oliguric
patients, clinical risk factors especially with respect to age,
duration of surgery, and surgical trauma need to be considered to
assess the individual risk for AKI following surgery.Acknowledgments
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